Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow.

Fraizer GC, Patmasiriwat P, Zhang X, Saunders GF.

Blood. 1995 Dec 15;86(12):4704-6. No abstract available.

2.

Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.

Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E.

Leukemia. 1995 Jun;9(6):1060-7.

PMID:
7596170
3.

Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.

Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T.

Blood. 1996 Apr 1;87(7):2878-84.

4.
5.

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.

Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H.

Blood. 1997 Feb 15;89(4):1405-12.

6.

Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.

Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.

Cancer Res. 2006 Oct 15;66(20):9967-76.

7.

Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia.

Tamaki H, Ogawa H, Inoue K, Soma T, Yamagami T, Miyake S, Oka Y, Oji Y, Tatekawa T, Tsuboi A, Tagawa S, Kitani T, Aozasa K, Kishimoto T, Sugiyama H, Miwa H, Kita K.

Blood. 1996 Dec 1;88(11):4396-8. No abstract available.

8.

Mutations in the Wilms' tumor gene WT1 in leukemias.

King-Underwood L, Renshaw J, Pritchard-Jones K.

Blood. 1996 Mar 15;87(6):2171-9.

9.

Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.

Miyazaki K, Yamasaki N, Oda H, Kuwata T, Kanno Y, Miyazaki M, Komeno Y, Kitaura J, Honda Z, Warming S, Jenkins NA, Copeland NG, Kitamura T, Nakamura T, Honda H.

Blood. 2009 May 7;113(19):4702-10. doi: 10.1182/blood-2007-05-088724. Epub 2009 Feb 20.

10.

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA, Calabretta B.

Nat Genet. 2002 Jan;30(1):48-58. Epub 2001 Dec 20.

PMID:
11753385
11.

Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.

Koschmieder S, Gƶttgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL, Dayaram T, Geary K, Green AR, Tenen DG, Huettner CS.

Blood. 2005 Jan 1;105(1):324-34. Epub 2004 Aug 26.

12.

The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.

Hosen N, Shirakata T, Nishida S, Yanagihara M, Tsuboi A, Kawakami M, Oji Y, Oka Y, Okabe M, Tan B, Sugiyama H, Weissman IL.

Leukemia. 2007 Aug;21(8):1783-91. Epub 2007 May 24.

PMID:
17525726
13.

A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.

Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ.

Oncogene. 1996 Mar 7;12(5):1005-14.

PMID:
8649791
14.

[Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].

Wu X, Wang Y, Pei X.

Zhonghua Xue Ye Xue Za Zhi. 1998 Jan;19(1):16-9. Chinese.

PMID:
10921096
15.

Expression of cell cycle regulatory genes in chronic myelogenous leukemia.

Iolascon A, Della Ragione F, Giordani L, Serra A, Saglio G, Faienza MF.

Haematologica. 1998 Sep;83(9):771-7.

16.

Overexpression of EVI-1 in blast crisis of chronic myeloid leukemia.

Carapeti M, Goldman JM, Cross NC.

Leukemia. 1996 Sep;10(9):1561. No abstract available.

PMID:
8751483
17.

Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.

Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, Dohy H, Niho Y.

Blood. 1996 Jun 1;87(11):4789-96.

18.

Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.

Werner H, Roberts CT Jr, Rauscher FJ 3rd, LeRoith D.

J Mol Neurosci. 1996 Summer;7(2):111-23.

PMID:
8873895
19.

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.

Gaiger A, Linnerth B, Mann G, Schmid D, Heinze G, Tisljar K, Haas OA, Gadner H, Lion T.

Eur J Haematol. 1999 Aug;63(2):86-93.

PMID:
10480287
20.

A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.

Scholz H, Bossone SA, Cohen HT, Akella U, Strauss WM, Sukhatme VP.

J Biol Chem. 1997 Dec 26;272(52):32836-46.

Supplemental Content

Support Center